跳至主要内容
临床试验/NCT04206774
NCT04206774已完成不适用

BIO|STREAM.ICM France, Submodule of the BIO|STREAM.ICM Registry

Biotronik SE & Co. KG3 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2020年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
3
主要终点
SADE free rate

研究概览

简要总结

The main objective of the BIO│STREAM.ICM France submodule is to provide clinical evidence from patients in France on safety and efficacy of the BIOMONITOR system

详细描述

The BIO|STREAM.ICM submodule will recruit a subset of patients with syncope with uncertain origin and cryptogenic stroke without history of atrial arrhythmia from the existing population enrolled in the BIO|STREAM.ICM registry. The submodule study is designed to provide clinical evidence from patients in France on safety and efficacy of the BIOMONITOR System.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for ICM device in accordance with the European guidelines: syncope with uncertain origin or cryptogenic stroke without history of atrial arrhythmia
  • Enrolled in the BIO|STREAM.ICM registry

排除标准

  • Life-expectancy is less than 3 months
  • Already implanted with BIOMONITOR

结局指标

主要结局

SADE free rate

时间窗: 3 month

Serious adverse device effect (SADE) free rate related to the BIOMONITOR system

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验